Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner
Posted January 18th, 2019. Filed under Concentrics NewsTags: FDA, Naloxone, Pivotal Study
Tag Archives: FDA
Tags: FDA, Naloxone, Pivotal Study